Skip to main content
. Author manuscript; available in PMC: 2019 Jul 1.
Published in final edited form as: Biotechnol Adv. 2018 Feb 28;36(4):935–953. doi: 10.1016/j.biotechadv.2018.02.014

Figure 1. Process for Fatty Acid Drug Discovery (FADD) approach.

Figure 1

Illustration depicts the processes of traditional versus reverse pharmacology. Using fatty acids as drug biosynthesizing candidates, reverse pharmacology is a feasible, more cost-effective method to develop novel molecules to combat diseases associated with conditions such as aging, inflammation, injury, and infection. eicosapentaenoic acid (EPA); docosahexaenoic acid (DHA)